Publicaciones en colaboración con investigadores/as de Tongji University (11)

2024

  1. Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial

    Lung Cancer, Vol. 189

2023

  1. Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

    New England Journal of Medicine, Vol. 389, Núm. 22, pp. 2039-2051

2022

  1. Editorial: HFpEF and HFmrEF: Different Sides of the Same Coin?

    Frontiers in Cardiovascular Medicine

2021

  1. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial

    The Lancet, Vol. 398, Núm. 10317, pp. 2149-2159

  2. Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review

    Journal of the American College of Cardiology, Vol. 78, Núm. 8, pp. 840-853

2019

  1. An international perspective on hospitalized patients with viral community-acquired pneumonia

    European Journal of Internal Medicine, Vol. 60, pp. 54-70

  2. Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention: A Global Expert Consensus Document

    Circulation, Vol. 140, Núm. 5, pp. 420-433

  3. International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia

    Journal of Infection, Vol. 79, Núm. 4, pp. 300-311

  4. Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer

    Lung Cancer, Vol. 132, pp. 126-131

2018

  1. Microbiological testing of adults hospitalised with community-acquired pneumonia: An international study

    ERJ Open Research, Vol. 4, Núm. 4

2010

  1. Iloprost-different indications and different national experiences in treating pulmonary hypertension

    Clinical Research in Cardiology Supplements, Vol. 5, Núm. SUPPL.2, pp. 19-23